Our COVID-19 Response:

Visit the InvisiMask™ Information page to learn about the InvisiMask nasal spray, our investigational daily human antibody nasal spray to provide active protection against COVID-19.

Harnessing the evolutionary power of the immune system with the goal of curing cancer

Focusing on developing safe and effective T-cell therapies with the potential to be widely accessible to cancer patients

learn more

Two proprietary platforms:

ArtemiS®

Utilizing the natural biology of T-cells to fight cancer

E-Alpha®

Leveraging antibody discovery platform to develop highly specific antibodies

learn more

A robust pipeline that encompasses T-cell therapies targeting a variety of tumor antigens

learn more